Objective
The field of Human Papillomavirus (HPV) research celebrates since the early 80's an annual conference in which recent results from basic research and the rapidly expanding clinical implications of HPV tests are extensively presented and discussed. Few disciplines in biology and medicine have experienced the expansion and the multidisciplinary that has characterised HPV research in the last decade.
An expected number of 800-850 experts typically contribute some 600-650 abstracts. The last European Conference was held in Sienna, Italy (September 1997) and next will be held in Barcelona, Spain in July 2000 (acronym HPV-2000).
Expected highlights at the HPV - 2000 conference in the basic sciences will include advances in the description of the structure of the PV capsid, characterisation and generation of chimeric PV capsids and studies on the cell surface HPV recptors (i.e. alpha-6 integrin).
Other areas of intensive research include cellular immunity studies, viral and host interactions and viral protein functions. In relation to the clinical implications of HPV research, conclusive results are expected from trials using HPV testing as a complement or as a stand-alone screening test.
Progress in HPV vaccine development will be a major topic, including developments in mucosal vaccines. Results are expected from early Phase I and II vaccination trials using either prophylactic (L1 based VLPs) or therapeutic (L1/E7 VLPs) products. Evaluation of novel HPV markers (i.e. quantitative PCRs, HPV integration and other genetic markers) as prognostic is another area in which progress is expected.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences biochemistry biomolecules proteins
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs vaccines
- medical and health sciences clinical medicine oncology cervical cancer
- medical and health sciences health sciences infectious diseases DNA viruses
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
08029 BARCELONA
Spain
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.